Host cells containing multiple integrating vectors
View Patent ↗The present invention relates to the production of proteins in host cells, and more particularly to host cells containing multiple integrated copies of an integrating vector. Suitable integrating vectors for use in the present invention include retrovirus vectors, lentivirus vectors, transposon vectors, and adeno-associated virus vectors. Methods are provided in which the host cells are prepared by using the integrating vectors at a high multiplicity of infection. The host cells are useful for producing pharmaceutical proteins, variants of proteins for use in screening assays, and for direct use in high throughput screening.
1. A host cell comprising a genome, said genome comprising at least 10 integrated copies of a first retroviral vector encoding a first gene of interest and at least 10 integrated copies of second retroviral vector encoding a second gene of interest.
2. The host cell of claim 1 , wherein said first and second genes of interest are subunits of a protein.
3. The host cell of claim 2 , wherein said first gene of interest encodes a heavy chain of an antibody and said second gene of interest encodes a light chain of an antibody.
4. The host cell of claim 1 , wherein said first and second retroviral vectors further comprise an RNA export element operably linked to exogenous genes.
5. The host cell of claim 1 , wherein said retroviral vectors are lentiviral vectors.
6. The host cell of claim 1 , wherein said host cell is selected from Chinese hamster ovary cells, baby hamster kidney cells, and bovine mammary epithelial cells.
7. The host cell of claim 1 , wherein said exogenous genes are operably linked to promoters.
8. The host cell of claim 7 , wherein said promoters are selected from the group consisting of alpha-lactalbumin promoter, cytomegalovirus promoter and the long terminal repeat of Moloney murine leukemia virus.
9. A clonally selected host cell comprising a genome, said genome comprising at least 10 copies of a first integrated retroviral vector, wherein said first retroviral vectors comprise at least one first exogenous gene operably linked to a promoter, said genome further comprising at least 1 copy of a second integrated retroviral vector, wherein said second retroviral vector comprises at least one second exogenous gene operably linked to a promoter, wherein said host cell does not produce infectious retroviral particles.
10. The host cell of claim 9 , wherein said host cell is selected from Chinese hamster ovary cells, baby hamster kidney cells, and bovine mammary epithelial cells.
11. The host cell of claim 9 , wherein said promoter is selected from the group consisting of alpha-lactalbumin promoter, cytomegalovirus promoter and the long terminal repeat of Moloney murine leukemia virus.
12. The host cell of claim 9 , wherein said first exogenous gene encodes one of an immunoglobulin heavy or light chain and the second exogenous gene encodes the other of an immunoglobulin heavy or light chain.
13. The host cell of claim 12 , wherein said host cells secretes an immunoglobulin.
14. A clonally selected host cell comprising a genome, said genome comprising at least three integrated retroviral vectors, said at least three integrated retroviral vectors each encoding a different exogenous gene operably linked to a promoter so that the exogenous gene is expressed in said host cell.